Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SGLT2i”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06453577
What this trial is testing

Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
Universität des Saarlandes 33
Not applicableUnknownNCT04862858
What this trial is testing

Educational Intervention to Increase Select Guideline-recommended Cardioprotective Medications in Patients With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular Diseases
Humana Inc. 4,197
Early research (Phase 1)Looking for participantsNCT05521984
What this trial is testing

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Who this might be right for
Pediatric Brain TumorPediatric Solid Tumor
Washington University School of Medicine 20
Post-approval studies (Phase 4)Looking for participantsNCT06364930
What this trial is testing

SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong 412
Post-approval studies (Phase 4)Ended earlyNCT05346653
What this trial is testing

The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
University of Chicago 1
Not applicableUnknownNCT06344247
What this trial is testing

Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Who this might be right for
ObesityChronic Kidney Diseases
RenJi Hospital 48
Post-approval studies (Phase 4)UnknownNCT03398577
What this trial is testing

Effects of SGLT2 Inhibitor in Diabetic Patients With Coronary Artery Disease

Who this might be right for
Coronary Disease With Diabetes Mellitus
Sheba Medical Center 61
Early research (Phase 1)Looking for participantsNCT07172971
What this trial is testing

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Vanderbilt University Medical Center 10
Post-approval studies (Phase 4)Looking for participantsNCT07572032
What this trial is testing

Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

Who this might be right for
Heart Failure Due to Coronary Artery DiseaseValvular CardiomyopathyHeart Failure
Kyungsub Song 80
Large-scale testing (Phase 3)Looking for participantsNCT07056699
What this trial is testing

SGLT2i, Pioglitazone, and Ketone Production in T1D

Who this might be right for
Type1diabetes
The University of Texas Health Science Center at San Antonio 24
Not applicableLooking for participantsNCT06585761
What this trial is testing

Effect of Sodium Glucose Co-tansporter 2 Inhibitors (SGLT2I) on Inflammatory and Oxidative Stress Markers Level in Heart Failure Patients

Who this might be right for
Heart Failure
Kafrelsheikh University 60
Large-scale testing (Phase 3)Study completedNCT04304261
What this trial is testing

Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)

Who this might be right for
Diabetes Mellitus, Type 2Cognitive Functions Confusion
Third Military Medical University 100
Early research (Phase 1)Looking for participantsNCT07053319
What this trial is testing

SGLT2i, Pioglitazone, and Ketone Production in T2D

Who this might be right for
Type 2 Diabetes
The University of Texas Health Science Center at San Antonio 64
Post-approval studies (Phase 4)UnknownNCT06401343
What this trial is testing

Use of SGLT2i in noHCM With HFpEF

Who this might be right for
Hypertrophic CardiomyopathyHeart Failure With Preserved Ejection Fraction
China National Center for Cardiovascular Diseases 94
Large-scale testing (Phase 3)Study completedNCT06469645
What this trial is testing

The Role of SGLT2i in Management of Moderate AS

Who this might be right for
Moderate Aortic Valve Stenosis
University of East Anglia 104
Early research (Phase 1)Study completedNCT06753994
What this trial is testing

Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

Who this might be right for
DiabetesType1diabetesT1D
McGill University 24
Large-scale testing (Phase 3)Study completedNCT03979352
What this trial is testing

Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting

Who this might be right for
Type1 Diabetes Mellitus
Samuel Lunenfeld Research Institute, Mount Sinai Hospital 28
Not applicableStudy completedNCT05990296
What this trial is testing

Evaluating Strategies to Improve Guideline Directed Medical Therapy: The GDMT Research, Education & Assist Trial for Heart Failure Care

Who this might be right for
Heart FailureHeart Failure With Reduced Ejection Fraction
Geisinger Clinic 4,306
Testing effectiveness (Phase 2)Study completedNCT04545411
What this trial is testing

Combination GRA and SGLT-2i Treatment in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of California, San Diego 12
Large-scale testing (Phase 3)UnknownNCT05310916
What this trial is testing

Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients

Who this might be right for
Diabetic Retinopathy
Nidae Alaa 60
Next Page